PURPOSE: To test the hypothesis that a carbamylated EPO-FC fusion protein (cEPO-FC) or recombinant human erythropoietin (rhEPO) would protect against kidney ischemia/reperfusion (I/R) injury in pigs with atherosclerosis. METHODS: Anesthetized and mechanically ventilated animals received cEPO-FC (50 μg kg(-1)), rhEPO (5,000 IU kg(-1)), or vehicle (n = 9 per group) prior to 120 min of aortic occlusion and over 4 h of reperfusion. During aortic occlusion, mean arterial pressure (MAP) was maintained at 80-120 % of baseline values by esmolol, nitroglycerin, and ATP. During reperfusion, noradrenaline was titrated to keep MAP at pre-ischemic levels. Blood creatinine and neutrophil gelatinase-associated lipocalin (NGAL) levels, creatinine clearance, fractional Na(+) excretion, and HE and PAS staining were used to assess kidney function and histological damage. Plasma interleukin-6, tumor necrosis factor-α, nitrate + nitrite and 8-isoprostane levels were measured to assess systemic inflammation, and nitrosative and oxidative stress. RESULTS: I/R caused acute kidney injury with reduced creatinine clearance, increased fractional Na(+) excretion and NGAL levels, moderate to severe glomerular and tubular damage and apoptosis, systemic inflammation and oxidative and nitrosative stress, but there were no differences between the treatment groups. Pre-ischemia nitrate + nitrite and 8-isoprostanes levels were lower and higher, respectively, than in healthy animals of a previous study, and immune histochemistry showed higher endothelial nitric oxide synthase and lower EPO receptor expression in pre-ischemia kidney biopsies than in biopsies from healthy animals. CONCLUSIONS: In swine with atherosclerosis, rhEPO and cEPO-FC failed to attenuate prolonged ischemia-induced kidney injury within an 8-h reperfusion period, possibly due to reduced EPO receptor expression resulting from pre-existing oxidative stress and/or reduced NO release.
PURPOSE: To test the hypothesis that a carbamylated EPO-FC fusion protein (cEPO-FC) or recombinant humanerythropoietin (rhEPO) would protect against kidney ischemia/reperfusion (I/R) injury in pigs with atherosclerosis. METHODS: Anesthetized and mechanically ventilated animals received cEPO-FC (50 μg kg(-1)), rhEPO (5,000 IU kg(-1)), or vehicle (n = 9 per group) prior to 120 min of aortic occlusion and over 4 h of reperfusion. During aortic occlusion, mean arterial pressure (MAP) was maintained at 80-120 % of baseline values by esmolol, nitroglycerin, and ATP. During reperfusion, noradrenaline was titrated to keep MAP at pre-ischemic levels. Blood creatinine and neutrophil gelatinase-associated lipocalin (NGAL) levels, creatinine clearance, fractional Na(+) excretion, and HE and PAS staining were used to assess kidney function and histological damage. Plasma interleukin-6, tumor necrosis factor-α, nitrate + nitrite and 8-isoprostane levels were measured to assess systemic inflammation, and nitrosative and oxidative stress. RESULTS: I/R caused acute kidney injury with reduced creatinine clearance, increased fractional Na(+) excretion and NGAL levels, moderate to severe glomerular and tubular damage and apoptosis, systemic inflammation and oxidative and nitrosative stress, but there were no differences between the treatment groups. Pre-ischemianitrate + nitrite and 8-isoprostanes levels were lower and higher, respectively, than in healthy animals of a previous study, and immune histochemistry showed higher endothelial nitric oxide synthase and lower EPO receptor expression in pre-ischemia kidney biopsies than in biopsies from healthy animals. CONCLUSIONS: In swine with atherosclerosis, rhEPO and cEPO-FC failed to attenuate prolonged ischemia-induced kidney injury within an 8-h reperfusion period, possibly due to reduced EPO receptor expression resulting from pre-existing oxidative stress and/or reduced NO release.
Authors: Livius V d'Uscio; Leslie A Smith; Anantha V Santhanam; Darcy Richardson; Karl A Nath; Zvonimir S Katusic Journal: Hypertension Date: 2007-03-19 Impact factor: 10.190
Authors: Kim E Jie; Marianne C Verhaar; Maarten-Jan M Cramer; Karien van der Putten; Carlo A J M Gaillard; Pieter A Doevendans; Hein A Koomans; Jaap A Joles; Branko Braam Journal: Am J Physiol Renal Physiol Date: 2006-08-01
Authors: Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami Journal: Proc Natl Acad Sci U S A Date: 2004-09-29 Impact factor: 11.205
Authors: Mitchell R Humphreys; Erik P Castle; Christine M Lohse; Thomas J Sebo; Kevin O Leslie; Paul E Andrews Journal: Int J Urol Date: 2009-01 Impact factor: 3.369
Authors: Alejandro R Chade; Martin Rodriguez-Porcel; Joerg Herrmann; Xiangyang Zhu; Joseph P Grande; Claudio Napoli; Amir Lerman; Lilach O Lerman Journal: J Am Soc Nephrol Date: 2004-04 Impact factor: 10.121
Authors: Oscar McCook; Peter Radermacher; Chiara Volani; Pierre Asfar; Anita Ignatius; Julia Kemmler; Peter Möller; Csaba Szabó; Matthew Whiteman; Mark E Wood; Rui Wang; Michael Georgieff; Ulrich Wachter Journal: Nitric Oxide Date: 2014-03-18 Impact factor: 4.427
Authors: Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit Journal: Intensive Care Med Date: 2014-01-24 Impact factor: 17.440
Authors: Mark de Caestecker; Ben D Humphreys; Kathleen D Liu; William H Fissell; Jorge Cerda; Thomas D Nolin; David Askenazi; Girish Mour; Frank E Harrell; Nick Pullen; Mark D Okusa; Sarah Faubel Journal: J Am Soc Nephrol Date: 2015-11-04 Impact factor: 10.121
Authors: Philippa Sleeman; Nishith N Patel; Hua Lin; Graham J Walkden; Paramita Ray; Gavin I Welsh; Simon C Satchell; Gavin J Murphy Journal: Crit Care Date: 2013-10-31 Impact factor: 9.097
Authors: Pamella A Malagrino; Gabriela Venturini; Patrícia S Yogi; Rafael Dariolli; Kallyandra Padilha; Bianca Kiers; Tamiris C Gois; Joaquim M da Motta-Leal-Filho; Celso K Takimura; Adriana C C Girardi; Francisco C Carnevale; Ana C M Zeri; Denise M A C Malheiros; José E Krieger; Alexandre C Pereira Journal: Physiol Rep Date: 2014-09-28
Authors: Benedikt L Nußbaum; Oscar McCook; Clair Hartmann; José Matallo; Martin Wepler; Elena Antonucci; Miriam Kalbitz; Markus Huber-Lang; Michael Georgieff; Enrico Calzia; Peter Radermacher; Sebastian Hafner Journal: Intensive Care Med Exp Date: 2016-06-06
Authors: Deborah J Gow; Kristin A Sauter; Clare Pridans; Lindsey Moffat; Anuj Sehgal; Ben M Stutchfield; Sobia Raza; Philippa M Beard; Yi Ting Tsai; Graeme Bainbridge; Pamela L Boner; Greg Fici; David Garcia-Tapia; Roger A Martin; Theodore Oliphant; John A Shelly; Raksha Tiwari; Thomas L Wilson; Lee B Smith; Neil A Mabbott; David A Hume Journal: Mol Ther Date: 2014-06-25 Impact factor: 11.454